CA2897188A1 - Procedes et compositions associes a des cellules souches cd34 - Google Patents

Procedes et compositions associes a des cellules souches cd34 Download PDF

Info

Publication number
CA2897188A1
CA2897188A1 CA2897188A CA2897188A CA2897188A1 CA 2897188 A1 CA2897188 A1 CA 2897188A1 CA 2897188 A CA2897188 A CA 2897188A CA 2897188 A CA2897188 A CA 2897188A CA 2897188 A1 CA2897188 A1 CA 2897188A1
Authority
CA
Canada
Prior art keywords
stem cells
cells
genetically modified
subject
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2897188A
Other languages
English (en)
Inventor
Ralf Huss
Peter Nelson
Matthias Raggi
Manfred Stangl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apceth GmbH and Co KG
Original Assignee
Apceth GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apceth GmbH and Co KG filed Critical Apceth GmbH and Co KG
Priority claimed from CA2688032A external-priority patent/CA2688032C/fr
Publication of CA2897188A1 publication Critical patent/CA2897188A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2897188A 2007-05-24 2008-05-20 Procedes et compositions associes a des cellules souches cd34 Abandoned CA2897188A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US93162207P 2007-05-24 2007-05-24
US60/931,622 2007-05-24
US305007P 2007-11-14 2007-11-14
US61/003,050 2007-11-14
CA2688032A CA2688032C (fr) 2007-05-24 2008-05-20 Procedes et compositions associes a des cellules souches cd34

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2688032A Division CA2688032C (fr) 2007-05-24 2008-05-20 Procedes et compositions associes a des cellules souches cd34

Publications (1)

Publication Number Publication Date
CA2897188A1 true CA2897188A1 (fr) 2008-12-11

Family

ID=53871572

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2897188A Abandoned CA2897188A1 (fr) 2007-05-24 2008-05-20 Procedes et compositions associes a des cellules souches cd34

Country Status (1)

Country Link
CA (1) CA2897188A1 (fr)

Similar Documents

Publication Publication Date Title
CA2688032C (fr) Procedes et compositions associes a des cellules souches cd34
Conrad et al. Genetically engineered stem cells for therapeutic gene delivery
CA2504019C (fr) Ecotaxie des cellules souches et regeneration tissulaire mediees par sdf-1 dans la myocardiopathie ischemique
CA2505213A1 (fr) Administration de vegf basee sur des cellules
WO2012064920A1 (fr) Procédés, compositions, cellules et kits pour traiter une lésion ischémique
JP2011503207A5 (fr)
Gao et al. Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages
CN115551554A (zh) 基因工程间充质干细胞及其应用
Zakirova et al. Use of biologically active 3D matrix for extensive skin defect treatment in veterinary practice: Case report
WO2019027299A2 (fr) Composition pharmaceutique pour la prévention ou le traitement de troubles vasculaires comprenant une cellule souche mésenchymateuse exprimant un facteur de croissance des hépatocytes en tant que principe actif
CN106459902B (zh) 组织再生促进剂
JP7144829B2 (ja) 安全性と抗炎症作用を高めた間葉系幹細胞
CA2897188A1 (fr) Procedes et compositions associes a des cellules souches cd34
KR100674140B1 (ko) 유전자 치료제
KR20190050277A (ko) 허혈성 심혈관 질환의 치료용 또는 예방용 약학 조성물
Quenneville et al. Ex vivo modification of cells to induce a muscle-based expression
Shah et al. Genetic modification of adipose-derived stem cells for bone regeneration
Bertolotti Stem cell gene therapy: breakthrough culminating in combination of ex vivo protocols with transient topical gene therapy
Lara-Pezzi et al. Genetic enhancement of cardiac regeneration
Jung et al. Genetically Engineered Mesenchymal Stem Cells for Cell and Gene Therapy
DiGirolamo The potential of human bone marrow stromal cells as vehicles for ex vivo gene therapy applications
AU2008200822A1 (en) Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150713

FZDE Dead

Effective date: 20170523